Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Medical Announces Higher Q3

publication date: Mar 2, 2009

China Medical Technologies, Inc. (中国医疗技术公司) reported another quarter of strong numbers. In its Q3 (ended December 31, 2008), China Medical’s revenues from continuing operations climbed 51% to 225 million RMB ($33.0 million) and non-GAAP net income was an amazing 95% higher at 119 million RMB ($17.5 million). That’s the snapshot, but the non-GAAP numbers exclude two significant one-time events: a one-time gain from its legacy HIFU (High Intensity Focused Ultrasound) business, and a one-time charge for acquired in-process research and development costs. More details...

Stock Symbol: (NSDQ: CMED)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here